Gemcitabine in Bone Sarcoma Resistant to Doxorubicin-Based Chemotherapy

Subjects and Methods: Seven patients with progressive localized or metastatic chemo-resistant osteosarcoma were treated by gemcitabine.The protocol included gemcitabine 1000 mg/m2/w for 7 consecutive weeks, followed by 1 week rest. If no progression was observed,maintenance by gemcitabine 1000 mg/m2...

Descripción completa

Detalles Bibliográficos
Autores principales: Merimsky, Ofer, Meller, Isaac, Kollender, Yehuda, Issakov, Josephine, Flusser, Gideon, Inbar, Moshe
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2000
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408365/
https://www.ncbi.nlm.nih.gov/pubmed/18521428
http://dx.doi.org/10.1155/S1357714X00000025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408365/
https://www.ncbi.nlm.nih.gov/pubmed/18521428
http://dx.doi.org/10.1155/S1357714X00000025

Ejemplares similares